Click here to

DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.

3 | A | B | C | D | E | F | G | H | I | K | L | M | N | O | P | Q | R | S | T | U | V | X | show all

Keywords: Treatment Verification
PO-GePV-M-63The Effects of Compton Camera Data Acquisition Timing and Readout On Prompt Gamma Images Acquired at Clinical Proton Beam Dose Rates
J Polf1*, P Maggi1, R Panthi2, D Mackin3, S Peterson4, S Beddar3, (1) University of Maryland School of Medicine, Baltimore, MD, (2) Rush University Medical Center, Chicago, IL, (3) MD Anderson Cancer Center, Houston, TX, (4) University of Cape Town, Rondebosch, ,ZA
PO-GePV-M-75Importance of Incorporating Rotational Setup Differences for QACT Dosimetric Evaluations
S Davis*, V Chaswal, R Tolakanahalli, Miami Cancer Institute, Miami, FL
PO-GePV-M-102Integrating Temporal Physical and Biological Dose Distribution Analysis in Imaged-Guided Hypofractionated Radiosurgery of High-Risk Brain Lesions
B Ziemer*, M Lafreniere, L Boreta, SE Braunstein, L Ma, University of California San Francisco Department of Radiation Oncology, San Francisco, CA
PO-GePV-T-105Dose-Averaged LET Evaluation in Head and Neck Adenoid Cystic Carcinoma Patients for Carbon-Ion Radiotherapy
R Kohno1*, S Lee2, A Yamamoto1, K Yamaoka1, M Suga3, M Koto1, (1) National Institute of Radio. Sciences, Chiba, JP, (2) Yamagata University, Yamagata, JP,(3) Kanagawa Cancer Center, Kanagawa, JP,
PO-GePV-T-133Wireless Device for Adaptive Planning Based Upon Thermoacoustic Range Estimates - Design and Benchtop Validation
S Patch1*, M Narayanaswamy2, (1) UW-Milwaukee, Milwaukee, WI, (2) Swamy Enterprises,
PO-GePV-T-134Sensitivity of Target Coverage and Patient Specific IMPT QA to Spot Positioning Errors
S Mossahebi1*, P Sabouri2, B Zhang1, E Makdsay Hana1, J Williams1, S Chen1, (1) University of Maryland Medical School, Baltimore, MD, (2) Miami Cancer Institute, Miami, FL
PO-GePV-T-188A Convolutional neural Network Model for Predicting Gamma Passing Rate of 3D Array Detector-Based VMAT QA
T Matsuura1,2*, D Kawahara2, A Saito3, E Shiba4, K Yamada1, S Ozawa1,2, Y Nagata1,2, (1) Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan, (2) Hiroshima University, Hiroshima, Japan, (3) Hiroshima University Hospital, Hiroshima, Japan, (4) Department of Radiation Oncology, Hospital of the University of Occupational and Environmental Health, Fukuoka, Japan
PO-GePV-T-366Evaluation of Parameters Affecting Gamma Passing Rate in Patient-Specific QA’s for Multiple Brain Lesions IMRS Treatments
E Salari*, D Shvydka, E Parsai, University of Toledo Medical Center, Toledo, OH
PO-GePV-T-412How Low Can We Go? Modified HyperArc VMAT Geometry for Recurrent Head and Neck SRT
D Pokhrel*, M Kudrimoti, M Bernard, University of Kentucky, Lexington, KY
SU-CD-TRACK 5-0Advances in Automatic Segmentation, Treatment Planning and QA
H Veeraraghavan1*, Q Wu2*, E Ford3*, S Jiang4*, (1) Memorial Sloan Kettering Cancer Center, New York, NY, (2) Duke University Medical Center, Durham, NC, (3) University of Washington, Seattle, WA, (4) UT Southwestern Medical Center, Dallas, TX
SU-CD-TRACK 5-1Deep Learning Automated Segmentation for Radiation Therapy Planning
H Veeraraghavan1*, Q Wu2*, E Ford3*, S Jiang4*, (1) Memorial Sloan Kettering Cancer Center, New York, NY, (2) Duke University Medical Center, Durham, NC, (3) University of Washington, Seattle, WA, (4) UT Southwestern Medical Center, Dallas, TX
SU-CD-TRACK 5-2Automation in Treatment Planning Process
H Veeraraghavan1*, Q Wu2*, E Ford3*, S Jiang4*, (1) Memorial Sloan Kettering Cancer Center, New York, NY, (2) Duke University Medical Center, Durham, NC, (3) University of Washington, Seattle, WA, (4) UT Southwestern Medical Center, Dallas, TX
SU-CD-TRACK 5-3Advances in Quality Assurance Through Automation
H Veeraraghavan1*, Q Wu2*, E Ford3*, S Jiang4*, (1) Memorial Sloan Kettering Cancer Center, New York, NY, (2) Duke University Medical Center, Durham, NC, (3) University of Washington, Seattle, WA, (4) UT Southwestern Medical Center, Dallas, TX
SU-CD-TRACK 5-4Thoughts on The Clinical Implementation of AI Tools In Treatment Planning Process
H Veeraraghavan1*, Q Wu2*, E Ford3*, S Jiang4*, (1) Memorial Sloan Kettering Cancer Center, New York, NY, (2) Duke University Medical Center, Durham, NC, (3) University of Washington, Seattle, WA, (4) UT Southwestern Medical Center, Dallas, TX
SU-F-TRACK 6-7Evaluating the Clinical Impact and Accuracy of Real-Time KV Imaging in Liver SBRT
A Santoso1*, Y Vinogradskiy1, T Robin1, K Goodman2, T Schefter1, M Miften1, B Jones1, (1) University of Colorado Anschutz Medical Campus, Aurora, CO, (2) Mount Sinai, New York, NY
TH-D-TRACK 5-7Ionoacoustic Treatment Monitoring for Radiosensitizer-Enhanced Carbon Ion Therapy: A Feasibility Study
J Lascaud*, M Wuerl, P Dash, M Nitta, K Parodi, Department of Medical Physics, Ludwig-Maximilians-Universitat Munchen
TH-F-TRACK 3-6Investigation Into the Relationship Patient Setup Accuracy and In-Vivo Transit Dosimetry for Image-Guided Volumetrically Modulated Total Body Irradiation (TBI)
S Taneja*, J Teruel, M Malin, P Galavis, A Mccarthy, S Ayyalasomayajula, C Hitchen, N Gerber, Y Yuan, D Barbee, NYU Langone Medical Center, New York, NY
WE-IePD-TRACK 6-1The Role of Surface-Guided Radiation Therapy to Improve Patient Safety
N Viscariello1*, H Al-Hallaq2, V Batista3, M Kugele4, E Ford1, J Meyer1, (1) University of Washington, Seattle, WA (2) The University of Chicago, Chicago, IL, (3) Heidelberg University Hospital, Heidelberg, DE (4) Lund University Hospital, Lund, ,SE
WE-IePD-TRACK 6-3Gradient-Dose Segmented Analysis (GDSA): An Improved Method for IMRT QA Analysis Compared to the Gamma Analysis
J Steers*, B Fraass, Cedars-Sinai Medical Center, Los Angeles, CA

Share: